Rafferty Asset Management, LLC
Position in FOLD — AMICUS THERAPEUTICS, INC.
CIK 1389426
New York, NY
Position in FOLD
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$4,538,733
-$2,482,840 QoQ
Shares Held
313,882
-36.3% QoQ
Ownership
0.100%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in FOLD Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Rafferty Asset Management, LLC holds $408,627,656 across 136 Biotechnology names. FOLD ranks #27 (1.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
54,572 | $24,368,580 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
29,589 | $22,861,644 | |
| 3 | INSM |
INSMED Inc
|
116,069 | $18,979,602 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
50,553 | $16,726,471 | |
| 5 | APLS |
Apellis Pharmaceuticals, Inc.
|
180,471 | $7,260,348 | |
| 6 | MRNA |
Moderna, Inc.
|
114,194 | $5,801,055 | |
| 7 | INCY |
Incyte Corp
|
60,565 | $5,700,377 | |
| 8 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
10,452 | $5,471,308 |
All Filings in FOLD
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,538,733 | 313,882 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $7,021,573 | 493,088 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $2,984,384 | 378,729 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $2,378,167 | 415,038 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $2,070,714 | 253,764 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $3,140,543 | 333,391 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $4,349,686 | 407,274 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $4,530,156 | 456,669 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $8,782,861 | 745,574 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $11,286,030 | 795,351 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $8,612,186 | 708,239 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $8,145,310 | 648,512 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $6,595,234 | 594,701 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $8,422,079 | 689,769 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $6,334,574 | 606,760 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $5,051,118 | 470,309 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $5,573,890 | 588,584 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $6,061,959 | 524,845 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $2,908,452 | 304,550 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $2,367,834 | 245,626 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $3,053,631 | 309,072 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $973,936 | 42,180 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $2,173,505 | 153,931 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $1,317,765 | 87,385 | Shares | Sole | 2020-08-07 | |
| 2020-03-31 | $329,784 | 35,691 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||